JRP Bio
AboutPipelinesBusinessPressContact
KOEN
Workspace
JRP Bio

Where botanicals meet evidence

JRP Bio standardizes traditional Korean medicine formulas and natural products, builds the evidence behind them, and secures regulatory approval to turn them into products people actually use.

JRP Bio is the business brand of Jaein R&P Co., Ltd.
Room 304, Global Center, Seoul Bio Hub, 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea

KOEN

Sitemap

  • About
  • Pipelines
  • Business
  • Press
  • Contact

Contact

  • bs@jrpbio.com
  • +82-2-6925-5568
  • Employee workspace
© 2026 Jaein R&P Co., Ltd. · All rights reserved.
← All press releases
Press releaseCompany2026.09

JRP Bio to open Jecheon Production Center in October

A base for producing its standardized botanical ingredients — the first production infrastructure for the Natural Products Foundry

JRP Bio (Jaein R&P Co., Ltd.) announced that it will open a production center in Jecheon, Chungcheongbuk-do, in October 2026.

The Jecheon Production Center will produce the botanical ingredients JRP Bio has standardized. The company runs every project through three steps — specification, evidence and approval — and in the first step documents raw material specs, manufacturing conditions, marker compounds and lot records so the same quality can be reproduced. The production center carries those specifications into actual production.

Over the long term, JRP Bio aims to build the Natural Products Foundry, development infrastructure where a single Korean medicine formula goes in and a product with specifications, evidence and approvals comes out. Building on lot, process and analytical data accumulated in its in-house data system JRP Labs, the company plans to expand step by step to a digital twin and an AI smart factory.

About JRP Bio

JRP Bio (Jaein R&P Co., Ltd.) standardizes Korean medicine formulas and natural products, builds the evidence behind them, and secures approval to turn them into products people actually use. JRP stands for “Journey from Research to People.” The company received Korea's first IND for an oral botanical anticancer candidate, SH003, and holds 14 granted Korean patents and 42 SCI(E) publications.

Media contact

  • Email bs@jrpbio.com
  • Phone +82-2-6925-5568
2026.03 →

JRP Bio granted Korean patent for immune-enhancing use of SH003